These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16254107)

  • 1. Aberrant expression of DeltaNp73 in benign and malignant tumours of the prostate: correlation with Gleason score.
    Guan M; Chen Y
    J Clin Pathol; 2005 Nov; 58(11):1175-9. PubMed ID: 16254107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival.
    Zitterbart K; Zavrelova I; Kadlecova J; Spesna R; Kratochvilova A; Pavelka Z; Sterba J
    Acta Neuropathol; 2007 Dec; 114(6):641-50. PubMed ID: 17912537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
    Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
    Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
    Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC
    Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the p53 family in lung cancer.
    Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Nozoe T; Yasumoto K
    Anticancer Res; 2006; 26(3A):1785-90. PubMed ID: 16827107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of TAp73 and ΔNp73 protein expression in ovarian cancer: a series of 83 cases and review of the literature.
    Hofstetter G; Berger A; Chamson M; Müller-Holzner E; Reimer D; Ulmer H; Uramoto H; Marth C; Zeimet AG; Zeillinger R; Concin N
    Int J Gynecol Pathol; 2011 Nov; 30(6):527-31. PubMed ID: 21979586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
    Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
    Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
    Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
    J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
    Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
    J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin receptor expression is upregulated in prostate cancer.
    Kaushal V; Kohli M; Dennis RA; Siegel ER; Chiles WW; Mukunyadzi P
    Prostate; 2006 Feb; 66(3):273-82. PubMed ID: 16245281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
    Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
    Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of p73 isoform equilibrium in benign prostate hyperplasia and prostate cancer.
    Arvanitis DA; Lianos E; Soulitzis N; Delakas D; Spandidos DA
    Oncol Rep; 2004 Nov; 12(5):1131-7. PubMed ID: 15492805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer.
    Di Vinci A; Sessa F; Casciano I; Banelli B; Franzi F; Brigati C; Allemanni G; Russo P; Dominioni L; Romani M
    Int J Oncol; 2009 Feb; 34(2):449-56. PubMed ID: 19148480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of deltaNp73 predicts poor prognosis in lung cancer.
    Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Morita M; Funa K; Yasumoto K
    Clin Cancer Res; 2004 Oct; 10(20):6905-11. PubMed ID: 15501968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
    Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
    Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
    Marabese M; Marchini S; Marrazzo E; Mariani P; Cattaneo D; Fossati R; Compagnoni A; Signorelli M; Moll UM; Codegoni AM; Broggini M
    Eur J Cancer; 2008 Jan; 44(1):131-41. PubMed ID: 18039564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic expression and quantitative RT-PCR study of TAp73 and DeltaNp73 in non-Hodgkin's lymphomas.
    Cuadros M; Ribas G; Fernández V; Rivas C; Benitez J; Martinez-Delgado B
    Leuk Res; 2006 Feb; 30(2):170-7. PubMed ID: 16083956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.